{"schema_version":"1","generated_at":"2026-11-10T17:41:41.891Z","data_as_of":"2026-11-09","url":"https://www.findmykol.com/kol/matteo-lambertini","json_url":"https://www.findmykol.com/kol/matteo-lambertini/profile.json","record_kind":"full","profile_kind":"research","person":{"slug":"matteo-lambertini","name":"Matteo Lambertini","credential":"MD","title":"Director of Medical Oncology, Galliera Hospital (Genoa)","specialty":"Medicine","therapeutic_area":"Breast","therapeutic_areas":["Breast","Oncology"],"institution":"Ente Ospedaliero Ospedali Galliera","institution_url":"https://www.findmykol.com/institution/ente-ospedaliero-ospedali-galliera","register":{"country":"IT"}},"identifiers":{"orcid":"0000-0003-1797-5296","openalex":"A5082293621"},"summary":"Matteo Lambertini is Director of Medical Oncology, Galliera Hospital (Genoa) at Ente Ospedaliero Ospedali Galliera. OpenAlex indexes 737 publications with 17,842 citations (h-index 67); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.","overview":{"text":"Matteo Lambertini is Director of Medical Oncology, Galliera Hospital (Genoa) at Ente Ospedaliero Ospedali Galliera. The public record shows 737 publications with 17,842 citations (h-index 67), centered on Breast Cancer Treatment Studies, BRCA gene mutations in cancer, Reproductive Biology and Fertility. It also documents an investigator role on 5 registered clinical trials.","bullets":["Most recent indexed publication: 2026 · European journal of clinical investigation","Top research focus: Breast Cancer Treatment Studies","5 registered trials on ClinicalTrials.gov"],"generated_at":"2026-11-10"},"focus":{"indications":[{"label":"Breast Cancer","therapeutic_area":"Oncology","trials":5,"topics":0,"strength":16},{"label":"Colorectal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Gastroesophageal Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Neuro-Oncology / Glioma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Hepatobiliary Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"HIV","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Idiopathic Pulmonary Fibrosis","therapeutic_area":"Respiratory","trials":0,"topics":0,"strength":1},{"label":"Leukemia (AML/ALL/CML/CLL)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Melanoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Lung Cancer (NSCLC/SCLC)","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Obesity","therapeutic_area":"Endocrinology/Metabolic","trials":0,"topics":0,"strength":1},{"label":"Ovarian / Gynecologic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Pancreatic Cancer","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Sarcoma","therapeutic_area":"Oncology","trials":0,"topics":0,"strength":1},{"label":"Viral Hepatitis (B/C)","therapeutic_area":"Gastroenterology","trials":0,"topics":0,"strength":1}],"research_topics":["Breast Cancer Treatment Studies","BRCA gene mutations in cancer","Reproductive Biology and Fertility","Advanced Breast Cancer Therapies","HER2/EGFR in Cancer Research"],"works_with":{"total":5,"shown":3,"withheld":2,"rows":[{"name":"Eli Lilly and Company","trials":1,"payments":0,"mentions":1},{"name":"Erasme University Hospital","trials":1,"payments":0,"mentions":1},{"name":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","trials":1,"payments":0,"mentions":1}]}},"scholarship":{"works_count":737,"cited_by_count":17842,"h_index":67,"i10_index":264,"pubmed_count":111,"latest_activity_year":2026,"source":"works"},"trials":{"count":5,"shown":3,"withheld":2,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT07591532","title":"Pregnancy Outcomes After Breast Cancer in Young Women With Germline Pathogenic Variants in Genes Other Than BRCA","status":"NOT_YET_RECRUITING","role":"Investigator","sponsor":"Jules Bordet Institute","source_url":"https://clinicaltrials.gov/study/NCT07591532","trial_url":"https://www.findmykol.com/trial/NCT07591532"},{"nct":"NCT07287098","title":"A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer","phase":"PHASE2","status":"RECRUITING","role":"Investigator","sponsor":"Eli Lilly and Company","source_url":"https://clinicaltrials.gov/study/NCT07287098","trial_url":"https://www.findmykol.com/trial/NCT07287098"},{"nct":"NCT05763992","title":"Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial","phase":"PHASE2","status":"UNKNOWN","role":"Investigator","sponsor":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","source_url":"https://clinicaltrials.gov/study/NCT05763992","trial_url":"https://www.findmykol.com/trial/NCT05763992"}],"source":"trials"},"payments":{"note":"Not attributed. This person has no U.S. clinical registration (NPI) on file, so industry payments cannot be reliably tied to them."},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"congress":{"count":140,"years":{"first":2013,"last":2026},"societies":["AACR","ASCO","ASH","ESHRE Annual Meeting","ESMO","ESTRO Congress","SABCS"],"shown":3,"withheld":137,"rows":[{"title":"Cumulative incidence and risk factors of trastuzumab deruxtecan–related interstitial lung disease in a multicenter real-world cohort.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.e15030","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e15030","status":"verified"},{"title":"De-escalated chemotherapy and endocrine therapy outcomes in young women with stage I HR+/HER2+ breast cancer: An international real-world study.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.e12512","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.e12512","status":"verified"},{"title":"Effectiveness of first-line ET+CDK4/6i continuation beyond disease progression in a large cohort of patients with HR+/HER2− advanced breast cancer: Results from the multicenter, real-world, Italian study PALMARES-2.","society":"ASCO","meeting":"ASCO Annual Meeting","year":2026,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1200/jco.2026.44.16_suppl.1017","source_url":"https://doi.org/10.1200/jco.2026.44.16_suppl.1017","status":"verified"}],"source":"congress"},"publications":{"total":111,"shown":5,"withheld":106,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Fertility Treatment and Risk of Melanoma: A Certainty-Rated Systematic Review and Meta-Analysis of 3,733,499 Women.","year":2026,"journal":"European journal of clinical investigation","types":["Journal Article","Systematic Review","Meta-Analysis","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42924873/","status":"verified"},{"title":"World Health Organization classification of tumours of the breast 6th edition 2026.","year":2026,"journal":"Histopathology","types":["Journal Article","Review"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42011085/","status":"verified"},{"title":"The benefit of adjuvant pertuzumab and trastuzumab according to estrogen receptor and HER2 expression: a subanalysis of the APHINITY trial.","year":2026,"journal":"Journal of the National Cancer Institute","types":["Journal Article","Randomized Controlled Trial","Clinical Trial, Phase III","Multicenter Study"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41934626/","status":"verified"},{"title":"Prognostic impact of phosphatase and tensin homolog status in recurrent IDH-wildtype glioblastoma receiving second-line therapy.","year":2026,"journal":"Neuro-oncology advances","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42614980/","status":"verified"},{"title":"Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort studies.","year":2026,"journal":"JNCI cancer spectrum","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42185079/","status":"verified"}],"source":"publications"},"presence":{"owned_accounts":{"total":1,"shown":1,"rows":[{"platform":"x","url":"https://x.com/matteolambe","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"social_posts":{"stored_total":16,"shown":3,"withheld":13,"rows":[{"platform":"x","post_id":"2115001635487330466","url":"https://x.com/matteolambe/status/2115001635487330466","handle":"matteolambe","posted_at_from_id":"2026-10-27T08:44:19.387Z","collected_at":"2026-11-05T21:43:34.520Z","sources":[{"hub":"esmo26","society_slug":"esmo","meeting_year":2026,"relevance":"explicit_hashtag","source_urls":["https://kolpulse.com/kol-pulse-esmo26-conference"]}]},{"platform":"x","post_id":"2114660906424480120","url":"https://x.com/matteolambe/status/2114660906424480120","handle":"matteolambe","posted_at_from_id":"2026-10-26T10:10:23.248Z","collected_at":"2026-11-05T21:43:34.520Z","sources":[{"hub":"esmo26","society_slug":"esmo","meeting_year":2026,"relevance":"explicit_hashtag","source_urls":["https://kolpulse.com/kol-pulse-esmo26-conference","https://kolpulse.com/kol-pulse-trial-profile-destinybreast09"]}]},{"platform":"x","post_id":"2114658048916799681","url":"https://x.com/matteolambe/status/2114658048916799681","handle":"matteolambe","posted_at_from_id":"2026-10-26T09:59:01.965Z","collected_at":"2026-11-05T21:43:34.520Z","sources":[{"hub":"esmo26","society_slug":"esmo","meeting_year":2026,"relevance":"explicit_hashtag","source_urls":["https://kolpulse.com/kol-pulse-trial-profile-bridget"]}]}],"coverage":"Saved references from selected congress pages, joined through reviewed account identifiers. Not a complete X history or evidence of attendance. Post availability may change."},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"MD, PhD","source_url":"https://youngsurvival.org/about/matteo-lambertini-md-phd","status":"provisional","collected_at":"2026-11-09"}]},"roles":{"total":6,"shown":3,"rows":[{"value":"Board member, ISFP","source_url":"https://cor2ed.com/experts/prof-matteo-lambertini/","status":"provisional","collected_at":"2026-11-09"},{"value":"Member of the executive board, Breast International Group (BIG)","source_url":"https://cor2ed.com/experts/prof-matteo-lambertini/","status":"provisional","collected_at":"2026-11-09"},{"value":"Member of the guideline group on fertility preservation in cancer patients, ESMO","source_url":"https://cor2ed.com/experts/prof-matteo-lambertini/","status":"provisional","collected_at":"2026-11-09"}]}},"similar":[{"name":"Nicoletta Sacchi","slug":"nicoletta-sacchi","institution":"Ente Ospedaliero Ospedali Galliera","url":"https://www.findmykol.com/kol/nicoletta-sacchi","json_url":"https://www.findmykol.com/kol/nicoletta-sacchi/profile.json"},{"name":"Cesare Massone","slug":"cesare-massone","institution":"Ente Ospedaliero Ospedali Galliera","url":"https://www.findmykol.com/kol/cesare-massone","json_url":"https://www.findmykol.com/kol/cesare-massone/profile.json"},{"name":"Claudio Marcello Solaro","slug":"claudio-solaro","institution":"Ente Ospedaliero Ospedali Galliera","url":"https://www.findmykol.com/kol/claudio-solaro","json_url":"https://www.findmykol.com/kol/claudio-solaro/profile.json"},{"name":"Arnoldo Piccardo","slug":"arnoldo-piccardo","institution":"Ente Ospedaliero Ospedali Galliera","url":"https://www.findmykol.com/kol/arnoldo-piccardo","json_url":"https://www.findmykol.com/kol/arnoldo-piccardo/profile.json"},{"name":"Gabriel Hortobagyi","slug":"gabriel-hortobagyi","institution":"The University of Texas MD Anderson Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gabriel-hortobagyi","json_url":"https://www.findmykol.com/kol/gabriel-hortobagyi/profile.json"},{"name":"Eric Winer","slug":"eric-winer","institution":"Yale School of Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/eric-winer","json_url":"https://www.findmykol.com/kol/eric-winer/profile.json"},{"name":"Norman Wolmark","slug":"norman-wolmark","institution":"University of Pittsburgh","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/norman-wolmark","json_url":"https://www.findmykol.com/kol/norman-wolmark/profile.json"},{"name":"Hope Rugo","slug":"hope-rugo","institution":"City of Hope","specialty":"Hematology","url":"https://www.findmykol.com/kol/hope-rugo","json_url":"https://www.findmykol.com/kol/hope-rugo/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":2,"congress":137,"publications":106,"social_posts":13}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-09"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-09"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-09"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-09"}},"methodology_url":"https://www.findmykol.com/about#methodology"}